Founded in 2005, Korea Institute for Pharmaceutical Policy Affairs, KIPPA, is a non-profit, public foundation, approved by the Korean Ministry of Health and Welfare. The institute is contributed by three relevant parties, the Korean Pharmaceutical Association (KPA), the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KBPMA), and the Korea Pharmaceutical Distribution Association (KPDA).

KIPPA is a leading research center, which aims to promote public health through the development of policy regarding the rational use of medicines, pharmacy education, pharmacy practice, pharmaceutical industry, and pharmaceutical supply and distribution. In particular, we begin to develop ¡®a community pharmacy model as a health promotion center for community members¡¯. We are collecting and analysing big data accordingly to develop pharmacy-based policies, which pursue maximised pharmacy practice for all the Koreans.

In consequence, KIPPA will consistently implement research tailored to the promotion of health in the nation and worldwide. We kindly ask for supports from our fellow pharmacists, public and associations.

If you have any further enquiries about the institute or research in English, please contact us via e-mail (kippa.org@gmail.com).

Thank you.

Office Address
3FL, 194, Hyoryeong-ro, Seocho-gu, Seoul, Repbulic of Korea

ÇöÀçÀ§Ä¡ : Home : ¾Ë¸²¸¶´ç : ¿¬±¸¼Ò ´º½º
   
¾Ë¸²¸¶´ç
°øÁö»çÇ×
º¸µµÀÚ·á
ÀÎÀçä¿ë
 
 
Á¦   ¸ñ [µ¥Àϸ®ÆÊ]ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò, ¿Â¶óÀÎ ÀÌ»çȸ ¿­°í »ç¾÷ È®Á¤
³»   ¿ë

ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò, ¿Â¶óÀÎ ÀÌ»çȸ ¿­°í »ç¾÷ È®Á¤

°­½Å±¹ ±âÀÚ 2020-04-01 06:10:05                    
                              

     

      
 ¡ã ¹ÚÇý°æ ÀǾàǰÁ¤Ã¥¿¬±¸¼ÒÀå

[µ¥Àϸ®ÆÊ=°­½Å±¹ ±âÀÚ] Àç´Ü¹ýÀÎ ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò(¼ÒÀå ¹ÚÇý°æ)´Â 30ÀÏ Á¤±âÀÌ»çȸ¸¦ ¿­°í Áö³­ÇØ ÁÖ¿ä ¾÷¹« ¹× »ç¾÷½ÇÀûÀ» º¸°íÇÏ°í ¿ÃÇØ »ç¾÷°èȹ µîÀÇ ¾È°ÇÀ» ½ÉÀÇÇß´Ù.

À̹ø Á¤±âÀÌ»çȸ´Â Äڷγª19 È®»ê ¹æÁö¿Í °ü·ÃµÈ Á¤ºÎÁöħ ÀÌÇà°ú ¿øÈ°ÇÑ ¾÷¹« ÃßÁøÀ» À§ÇØ ´ÙÀÚ°£ ¸Þ½ÅÀú ÇüÅÂÀÇ ¿Â¶óÀÎ ¹æ½ÄÀ¸·Î ÁøÇàµÆ´Ù.

±è´ë¾÷ ¿¬±¸¼Ò ÀÌ»çÀåÀº ȸÀÇ¿¡ ¾Õ¼­ "2019³â ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò´Â »ç¹«½ÇÀ» ÀÌÀüÇØ ´ëÇѾà»çȸ¸¦ ºñ·ÔÇØ ´Ù¾çÇÑ À¯°ü±â°ü°úÀÇ ¾÷¹« Çù·Â ½Ã³ÊÁö¸¦ ÀÌ·ê ¼ö ÀÖ¾ú´Ù"¸ç "Áö¿ªÁÖ¹ÎÀ» ´ë»óÀ¸·Î ¾à±¹ ¹× ¾à»ç°¡ Á¦°øÇϰí ÀÖ´Â ÀǾàǰ ¾ÈÀü»ç¿ë ±³À°, ¹æ¹®¾à·á, ¼¼ÀÌÇÁ¾à±¹ µî°ú °°Àº °³º°ÀûÀÎ ¼­ºñ½º¸¦ ¸ð¾Æ Áö¿ªÁÖ¹ÎÀ» À§ÇÑ °Ç°­Çãºê·Î¼­ÀÇ Áö¿ª¾à±¹ ¸ðµ¨À» ¿Ï¼ºÇذ¡±â À§ÇØ ÃÖ¼±ÀÇ ³ë·ÂÀ» ´ÙÇϰí ÀÖ´Ù¡±°í Æò°¡Çß´Ù.

¾Æ¿ï·¯ ±è ÀÌ»çÀåÀº "¿ÃÇØ¿¡ ´õ¿í ÀÇ¹Ì ÀÖ°í °¡Ä¡ ÀÖ´Â ¿¬±¸¼º°ú¸¦ °ÅµÑ ¼ö ÀÖµµ·Ï ¿©·¯ ÀÌ»ç´ÔÀÇ ¸¹Àº Áö¿øÀ» ºÎŹÇÑ´Ù"°í ´çºÎÇß´Ù.

¾È°Ç ½ÉÀÇ¿¡¼­´Â Á÷Á¦ °³Æí¿¡ °üÇÑ °Ç°ú º¹¹«±ÔÁ¤ °³Á¤¿¡ °üÇÑ °Ç µî ±ÔÁ¤ °³Á¤, 2019³âµµ °¨»ç º¸°í ¹× ¼öÀÔ¡¤ÁöÃâ µîÀÌ ¿ø¾È´ë·Î Åë°úµÆ´Ù.

À̾îÁø ȸÀÇ¿¡¼­´Â '°ø°ø½É¾ß¾à±¹ »ç¾÷ Æò°¡' µî 15°³ÀÇ ¿¬±¸»ç¾÷°ú ÀǾàǰÁ¤Ã¥¿¬±¸ ¹ß°£»ç¾÷, Á¤Ã¥Æ÷·³ ¹× ±¹Á¦½ÉÆ÷Áö¾ö °³ÃÖ µîÀ» Æ÷ÇÔÇÑ ¿ÃÇØ »ç¾÷°èȹ°ú ¿¹»ó¾Èµµ ¿ø¾È´ë·Î ½ÂÀÎÇß´Ù.

¹ÚÇý°æ ¼ÒÀåÀº "ÀÛ³â°ú ºñ±³ÇØ Áõ°¡µÈ ¿¹»ê°ú »õ·Î Ãæ¿øµÈ ¿¬±¸ÀηÂÀ» Åä´ë·Î ÀÇ¹Ì ÀÖ´Â ¿¬±¸¼º°ú âÃâÀ» À§ÇØ ÃÖ¼±ÀÇ ³ë·ÂÀ» ´ÙÇϰڴÙ"¸ç ÀÓ¿øµéÀÇ Àû±ØÀûÀÎ °ü½É°ú Âü¿©¸¦ ¿äûÇß´Ù.
°­½Å±¹ ±âÀÚ (ksk@dailypharm.com)


http://www.dailypharm.com/Users/News/NewsView.html?ID=263379&REFERER=NP


 

¹øÈ£ ÷ºÎ Á¦¸ñ ÀÛ¼ºÀÚ ÀÛ¼ºÀÏ Á¶È¸
9 [µ¥Àϸ®ÆÊ]¾à±¹ Á÷¿ø ¾÷¹«¹üÀ§ ÇØ¿Üµµ '±Ø°ú ±Ø'¡¦±¹³»´Â ¾î¶»°Ô? ±è¼±Èñ 2020-04-09 1140
8 [¾à»ç°ø·Ð]ÀǾàǰÁ¤Ã¥¿¬, Áö¿ª¾à±¹ ¸ðµ¨ ¿Ï¼º ³ë·Â¡¦Á¤±âÀÌ»çȸ °³ÃÖ ±è¼±Èñ 2020-04-09 735
7 [µ¥Àϸ®ÆÊ]ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò, ¿Â¶óÀÎ ÀÌ»çȸ ¿­°í »ç¾÷ È®Á¤ ±è¼±Èñ 2020-04-09 753
6 [´ëÇѾà»çÀú³Î]»ç·Ê °íÂûÀ» ÅëÇÑ ¹Ù¶÷Á÷ÇÑ ¾à»ç¿¬¼ö±³À°ÀÇ ¹æÇâ 4 ±è¼±Èñ 2020-04-09 721
5 [´ëÇѾà»çÀú³Î]»ç·Ê °íÂûÀ» ÅëÇÑ ¹Ù¶÷Á÷ÇÑ ¾à»ç¿¬¼ö±³À°ÀÇ ¹æÇâ 3 ±è¼±Èñ 2020-04-09 627
4 [´ëÇѾà»çÀú³Î]»ç·Ê °íÂûÀ» ÅëÇÑ ¹Ù¶÷Á÷ÇÑ ¾à»ç¿¬¼ö±³À°ÀÇ ¹æÇâ 2 ±è¼±Èñ 2020-03-24 737
3 [ÄíŰ´º½º]WHO, Àü¼¼°è ¸¶½ºÅ© »ý»ê·® 40% Áõ°¡ ÇÊ¿ä ±è¼±Èñ 2020-03-16 1226
2 [´ëÇѾà»çÀú³Î]¹Ì±¹, ½Ã´ë ¸ÂÃç ±³À°°ú¸ñ º¯È­¡¦»çÈÄÆò°¡µµ Àǹ«È­ ±è¼±Èñ 2020-03-16 922
1 [´ëÇѾà»çÀú³Î]ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò ¸®Æ÷Æ®: Ä¿¹Â´ÏƼÄɾî, ¼¼°èÀÇ ´äÀº ¡®¾à»ç¡¯¿´´Ù ±è¼±Èñ 2020-03-10 981

ÀÌÀü 10ÆäÀÌÁö [1]  [2]  [3]  [4]  [5]  [6]  [7]  [8]  [9]  ´ÙÀ½ 10ÆäÀÌÁö

 
 

¼­¿ï ¼­Ãʱ¸ È¿·É·Î194, 3Ãþ (Àç)ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò TEL : 02) 3474-5301 / FAX : 02)3474-5306

COPYRIGHT (C) 2006 KOREA INSTITUTE FOR PHARMACEUTICAL POLICY AFFAIRS ALL RIGHTS RESERVED. FOR MORE INFORMATION MAL kippa.org@gmail.com

±âºÎ±Ý ¾È³»